Vanguard Group Inc Shattuck Labs, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,408,454 shares of STTK stock, worth $3.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,408,454
Previous 2,401,909
0.27%
Holding current value
$3.3 Million
Previous $8.38 Million
65.24%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding STTK
# of Institutions
74Shares Held
31.3MCall Options Held
0Put Options Held
0-
Prosight Management, LP Dallas, TX6.64MShares$9.1 Million2.39% of portfolio
-
Redmile Group, LLC San Francisco, CA5.54MShares$7.59 Million0.52% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.68MShares$6.4 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$3.39 Million0.0% of portfolio
-
Clark Estates Inc New York, NY1.48MShares$2.02 Million0.48% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $58.1M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...